Comparative assessment of treatment outcomes of empagliflozin add-on metformin and sitagliptin add-on metformin therapies in uncontrolled type 2 diabetes mellitus: findings from an observational study in Pakistan
Empagliflozin as add on therapy in uncontrolled T2DM provided improvements in patients HbA1c, serum creatinine, and eGFR hence improving overall clinical outcomes and patient safety.
Authors
- Wajid Syed (ORCID: https://orcid.org/0000-0002-4077-4524)
- Muhammad Ashfaq (ORCID: https://orcid.org/0000-0001-6268-205X)
- Adel Bashatah (ORCID: https://orcid.org/0000-0003-3825-2812)
- Qasim Raza Khan (ORCID: https://orcid.org/0000-0003-1835-0239)
- Muhammad Junaid Hassan Sharif
- Ayesha Iqbal (ORCID: https://orcid.org/0000-0001-7282-471X)
- Naji Alqahtani (ORCID: https://orcid.org/0000-0001-9189-3841)
- Arif Ullah Khan (ORCID: https://orcid.org/0000-0002-0528-1871)
- Muhammad Mamoon Iqbal
Institutions
- University of Nottingham (GB)
- University of Leicester (GB)
- University of Alberta (CA)
- COMSATS University Islamabad (PK)
- King Saud University (SA)
- Abbottabad University of Science and Technology (PK)
Publication Details
- Journal
- Journal of Health Population and Nutrition
- Published
- 2025-08-21
- DOI
- https://doi.org/10.1186/s41043-025-01041-8
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- King Saud University